Why is an imprecise drug history a risk in the admission process?
Many patients report an “allergy to antibiotics” without being able to name the active substance, type of reaction or time. If this information is adopted uncritically, in practice it often leads to switching to reserve antibiotics or to an allergological work-up being flagged as necessary, although both could often be avoided with a more detailed medical history. An imprecise entry is therefore not a marginal documentation issue, but has a direct influence on perioperative medication.
According to the S2k guideline, what does a complete drug allergy history include?
The S2k guideline “Diagnostik bei Verdacht auf eine Betalaktamantibiotika-Überempfindlichkeit” (diagnostics in suspected beta-lactam antibiotic hypersensitivity; AWMF register no. 061-032, DGAKI in cooperation with AeDA, GPA, DKG, ÖGAI and PEG) dates from 2019 and is listed as expired in the AWMF register. It defines which information a reliable medical history contains:
- Triggering drug and timing – which drugs were taken before and at the time of the reaction.
- Time course – duration of intake, interval between last dose and onset of symptoms, duration of the reaction itself.
- Symptoms – organ systems affected in chronological order, laboratory findings where applicable.
- Accompanying factors – concurrent infections or physical exertion at the time of the reaction.
- History – previous intake of beta-lactam antibiotics and their tolerance.
- Background – age, atopic predisposition, current long-term medication.
This level of detail can hardly be captured in a conventional medical history form with an “Allergies” free-text field – it requires targeted follow-up questions that go beyond a single yes/no answer.
How do penicillins and cephalosporins actually cross-react?
The guideline contradicts the long-held assumption of general cross-reactivity between all beta-lactam antibiotics: only in isolated cases are people actually allergic to all members of this class of substances. The majority of patients allergic to penicillin tolerate certain cephalosporins without a reaction.
| Class of substances | Cross-reactivity with aminopenicillins |
|---|---|
| Aminocephalosporins (cefaclor, cefalexin, cefadroxil) | Relevant in some patients |
| Cefuroxime, ceftriaxone | Relevant only in isolated cases |
This differentiation can only be made on the basis of a complete medical history – the final evaluation and the decision on allergy testing remain the task of the treating physician or a physician specialising in allergology.
How does medudoc structure the medication and allergy history?
medudoc captures medication and pre-existing conditions in structured form instead of in a single free-text field. Through Medical Reasoning, the platform recognises when an entry such as “antibiotic allergy” is present without further details and asks targeted additional questions about the active substance, type of reaction and timing – information that the medical or allergology staff would need anyway, but which here is already available before the personal discussion. Medical Reasoning does not assess any allergy and does not make any medical decision; it only provides the information required for the physician’s assessment. The article smart medical history vs. digital questionnaire describes how this structured capture is embedded in the wider medical history process.
What does this mean for anaesthesia and the pre-anaesthesia clinic?
In premedication, the drug history is particularly time-critical because it directly influences the choice of antibiotic prophylaxis and anaesthetic agents. If the allergy history is already complete and structured before the clinic visit, the physician’s discussion can concentrate on the actual risk evaluation instead of re-collecting basic information on site – the same effect already described for other areas of the medical history in the article Avoiding duplicate examinations through a structured medical history.
Conclusion
A reliable drug allergy history consists of considerably more than the name of an active substance. The 2019 S2k guideline shows what level of detail is needed for a clinically sound classification – and that the vast majority of supposedly generalised beta-lactam allergies turn out to be more differentiated on closer inspection. A structured digital medical history creates the conditions for this differentiation not to begin only on the day of the procedure.
